InvestorsObserver
×
News Home

Will Talaris Therapeutics Inc (TALS) Beat the Rest of the Stocks in the Healthcare Sector?

Monday, October 16, 2023 10:40 AM | InvestorsObserver Analysts

Mentioned in this article

Will Talaris Therapeutics Inc (TALS) Beat the Rest of the Stocks in the Healthcare Sector?

Talaris Therapeutics Inc (TALS) is around the top of the Healthcare sector according to InvestorsObserver. TALS received an overall rating of 99, which means that it scores higher than 99% of stocks. Additionally, Talaris Therapeutics Inc scored a 84 in the Healthcare sector, ranking it higher than 84% of stocks in that sector.

Overall Score - 99
TALS has an Overall Score of 99. Find out what this means to you and get the rest of the rankings on TALS!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Talaris Therapeutics Inc Stock Today?

Talaris Therapeutics Inc (TALS) stock is trading at $2.99 as of 10:37 AM on Monday, Oct 16, an increase of $0.13, or 4.55% from the previous closing price of $2.86. The stock has traded between $2.91 and $3.13 so far today. Volume today is less active than usual. So far 51,069 shares have traded compared to average volume of 123,389 shares. Click Here to get the full Stock Report for Talaris Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App